Ticker: IONS

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has reported its quarterly results for the period ending June 30, 2025. The company has experienced notable financial shifts, partly due to its recent commercialization efforts. Key Highlights: Total Revenue: $452.0 million for Q2 2025, up from $225.3 m...

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) recently released its quarterly financial results for the three months ended March 31, 2025, showing significant developments in revenue and expenditures. Key Financial Highlights: Total Revenue: $131.6 million, an increase of approximately 10% from $11...